| Dr Ronit Herzog, MD | |
|
60 Fenwood Rd, Boston, MA 02115-6128 | |
| (617) 732-9850 | |
| Not Available |
| Full Name | Dr Ronit Herzog |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 33 Years |
| Location | 60 Fenwood Rd, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346317823 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asthma And Allergy Associates Pc | 0840216388 | 6 |
News Archive
African Union health ministers meeting in Maputo, Mozambique, last week adopted a policy framework to address sexual and reproductive health and rights but did not agree on how to address the issue of unsafe abortions, resolving to allow each member state to handle the issue separately, Lilongwe's Chronicle/AllAfrica.com reports.
Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment.
Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors.
› Verified 4 days ago
| Entity Name | Asthma & Allergy Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063503191 PECOS PAC ID: 0840216388 Enrollment ID: O20051024000403 |
News Archive
African Union health ministers meeting in Maputo, Mozambique, last week adopted a policy framework to address sexual and reproductive health and rights but did not agree on how to address the issue of unsafe abortions, resolving to allow each member state to handle the issue separately, Lilongwe's Chronicle/AllAfrica.com reports.
Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment.
Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors.
› Verified 4 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
African Union health ministers meeting in Maputo, Mozambique, last week adopted a policy framework to address sexual and reproductive health and rights but did not agree on how to address the issue of unsafe abortions, resolving to allow each member state to handle the issue separately, Lilongwe's Chronicle/AllAfrica.com reports.
Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment.
Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronit Herzog, MD 1 Columbus Pl Apt S47b, New York, NY 10019-8216 Ph: (917) 669-1863 | Dr Ronit Herzog, MD 60 Fenwood Rd, Boston, MA 02115-6128 Ph: (617) 732-9850 |
News Archive
African Union health ministers meeting in Maputo, Mozambique, last week adopted a policy framework to address sexual and reproductive health and rights but did not agree on how to address the issue of unsafe abortions, resolving to allow each member state to handle the issue separately, Lilongwe's Chronicle/AllAfrica.com reports.
Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment.
Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors.
› Verified 4 days ago
Puja Banka, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Bader 203, Boston, MA 02115 Phone: 617-355-6363 | |
Angela M. Jacques, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-2066 | |
Dr. Elizabeth Susan Taglauer, M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Cailyn Hereen Rood, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Dr. Alon Peltz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Miki Nishitani, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Vickren Pillay, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |